Digene at outperform by RBC

Digene Corp. was rated at outperform, above average risk, by RBC Capital Markets analyst William R. Quirk on stronger-than-expected results. Expenses yielded non-GAAP earnings per share of $0.21 compared to the analyst's estimate of $0.13 per share and Street consensus of $0.14. Digene management raised 2007 guidance to $192 million from $188 million. Shares of the Gaithersburg, Md.-based medical testing device company were up $4.30, or 10.72%, at $44.42, on volume of 3,162,508 shares versus the three-month running average of 307,531 shares. (Nasdaq: DIGE)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.